A study published in Nature Microbiology now shows for the first time that Candida auris uses a CO₂-based metabolic strategy to survive in the nutrient-poor conditions of the skin and to better tolerate antifungal therapies – especially amphotericin B (AMB).24. Dezember 2025
News Brook.ai Raises $28M to Scale Remote Care Model Nationwide –Healthradar17. Oktober 2025 What You Should Know: – Brook.ai is making remote care an integral part of U.S. healthcare, extending continuity of care outside…
